Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00005810 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: carboplatin
DRUG: docetaxel
DRUG: estramustine phosphate sodium

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]